A phase 2 trial assessing different doses of bimagrumab (up to 30 mg/kg) in combination with semaglutide as obesity treatment is ongoing (NCT05616013)
The theoretical risk exists, but clinical evidence does not support increased incidence with semaglutide use
CLICK HERE TO GET THE FOX NEWS APP "We are proud of the work our scientists have done to advance innovation and improve the lives of people with chronic diseases, including diabetes and obesity," the spokesperson added
*Correspondence: Hua Hao, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Glutathione Brightening Night Cream (30ML)
Is compounded semaglutide from Remedy Meds equivalent to branded Wegovy